← Every applicant
Becton Dickinson Infusion Therapy Systems, Inc. FDA Approvals
0 new drug approvals and 11 device clearances on file. Matched by name to BDX.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| BD Insyte IV Catheter510(k)Apr 2, 2026General Hospital |
| BD Saf-T-Intima Subcutaneous Catheter System510(k)Oct 8, 2025General Hospital |
| BD Nexiva Closed IV Catheter System510(k)Jul 25, 2025General Hospital |
| BD Cathena Safety IV Catheter510(k)Jul 11, 2025General Hospital |
| BD Insyte Autoguard Shielded IV Catheter, BD Insyte Autoguard BC Shielded IV Catheter and BD Insyte Autoguard BC Pro Shielded IV Catheter510(k)Jun 27, 2025General Hospital |
| BD Nexiva Diffusics Closed IV Catheter System and BD Nexiva Diffusics Closed IV Catheter System with BD MaxZero Needle-free Connector510(k)Jun 3, 2025General Hospital |
| PIVO Pro Needle-free Blood Collection Device510(k)Feb 27, 2025Clinical Chemistry |
| BD Nexiva Diffusics Closed IV Catheter System with BD MaxZero Needle-free Connector510(k)Dec 1, 2023General Hospital |
| PIVO Pro Needle-free Blood Collection Device510(k)Sep 28, 2023Clinical Chemistry |
| Nexiva Closed IV Catheter System with NearPort IV Access510(k)Sep 22, 2023General Hospital |
| BD Cathena Safety IV Catheter510(k)Mar 31, 2022General Hospital |